See All Slides - tctmd.com

Slides

Presentation TCT 2013

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Presenter: Stephan Windecker

October 30, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by OCT (with Case Vignettes)

Presenter: Ik-Kyung Jang

October 30, 2013

Presentation TCT 2013

Introducing the Case(2)

Presenter: Ping-Han Lo

October 30, 2013

Presentation TCT 2013

Are Regulatory Approval Clinical Trials Too Complex and Too Costly for New Devices and New Indications? EXCEL and BVS Experience.

Presenter: Charles Simonton

October 30, 2013

Presentation TCT 2013

FIH-Clinical Study Presentation: Percutaneous Annuloplasty: The Valtech Cardioband Approach

Presenter: Francesco Maisano

October 30, 2013

Presentation TCT 2013

Plaque Composition and Intervention

Presenter: Jagat Narula

October 30, 2013

Presentation TCT 2013

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

Presenter: David Kandzari

October 30, 2013

Presentation TCT 2013

When is a Second Stent Required (Planned and Provisional)

Presenter: Goran Stankovic

October 30, 2013

Presentation TCT 2013

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

Case Presentation 2: My Most Difficult Retrograde Approach Case in 2013

Presenter: J. Aaron Grantham

October 30, 2013

Advertisement

Slides

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Vulnerable Plaque Diagnosis by OCT (with Case Vignettes)

Introducing the Case(2)

Are Regulatory Approval Clinical Trials Too Complex and Too Costly for New Devices and New Indications? EXCEL and BVS Experience.

FIH-Clinical Study Presentation: Percutaneous Annuloplasty: The Valtech Cardioband Approach

Plaque Composition and Intervention

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

When is a Second Stent Required (Planned and Provisional)

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Case Presentation 2: My Most Difficult Retrograde Approach Case in 2013

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content